When we first wrote about EarlySense in January 2017 following CES, we noted the multisensory patient under-mattress monitor’s versatility and accuracy. The second part of the article focused on the potential benefits to patients and hospitals in early patient deterioration detection for better patient outcomes and reductions in the cost of care.

EarlySense recently released a report on its 2018 milestones and key statistics. During the past year EarlySense:

  • Monitored its one millionth patient
  • Saved 180,000 patient hospital days
  • Prevented 14,000 pressure ulcers
  • Saved more than 3,000 lives

Citing strong growth projections and per bed savings of $10,000, EarlySense expects to monitor three million additional patients by the end of 2022, which the company values as an overall savings of $3 billion for the hospitals that use EarlySense monitoring. The company also cited a partnership with Hill-Rom, a major hospital bed manufacturer as a contributing factor in its growth.

EarlySense’s 2018 reporting and future projections underscore a trend to B2B products instead of B2C sales we observe in health technology, including wearables. Hospitals, insurance companies, large employers, and other major institutions are the real future for health tech growth, especially for wearables. People are healthier with technology, but it is the substantial cost savings that will drive adoption by major institutions.